Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.
about
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and MechanismsAllergen Immunotherapy (AIT): a prototype of Precision MedicineNew treatments for allergen immunotherapySublingual immunotherapy: World Allergy Organization position paper 2013 update.Allergen sensitization linked to climate and age, not to intermittent-persistent rhinitis in a cross-sectional cohort study in the (sub)tropicsSystematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.History of symptom triggers in patients presenting to the emergency department for asthma.Assessment of disease control in allergic rhinitis.Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?Emerging drugs for perennial allergic rhinitis.Off-label prescriptions for atopic dermatitis in Europe.Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.Alternaria and Cladosporium calendar of Western Thrace: Relationship with allergic rhinitis symptoms.The clinical significance of the pollen calendar of the Western Thrace/northeast Greece region in allergic rhinitis.Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.New opportunities and challenges in the assessment of drugs for atopic diseases.Work productivity in rhinitis using cell phones: The MASK pilot study.microRNA and Allergy.Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control.Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.Reduced severity and improved control of self-reported asthma in Finland during 2001-2010.Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-lifeCHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament.A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone.Demographic correlates of anxiety and depression symptoms in chronic sinonasal diseases.Predictors of quality of life improvement in allergic rhinitis patients after sublingual immunotherapy.Improvement of olfactory function for quality of life recovery.The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study.
P2860
Q26740215-3005C4AD-18A7-4F51-BE07-83F5760C4E6AQ26747066-C52A9D89-0B1C-4EE3-9244-A6CA78F7647BQ26776512-4BE718E8-91D2-430D-9DF9-7C45584F90B1Q27016089-8C9C16F9-5DC0-453A-AB4B-74B12D9BCD72Q30440195-0366D116-0D38-4174-8F62-8D9DCC827A26Q33815162-E1E6D658-C1FD-4521-92F1-79AE93396D1EQ34454209-94DC4BA4-BB43-4D99-A081-3DC8975FC7C0Q36176661-29F63DE8-0E9C-47D7-975A-E696265332C7Q36738776-70B6AB44-2A9D-4EC5-A67B-40503729A51BQ38013789-EF9B45C2-8B4B-4248-90A5-B8BC6373BD83Q38048352-8D5B9B18-B70C-4D8E-94F5-E5F1C16AC2CEQ38062942-4986B7B5-F979-47DC-8D75-CEEE6B4BD16CQ38235225-E13BF21C-3AD2-4BAD-B39F-FFEFD5021C3AQ38369307-E5F565B8-AA71-493B-856D-0B1AEAF66772Q38412514-914D53AF-FF7B-4135-8084-A89FC10AD223Q38413189-54BF4231-0B0C-418A-8C28-54B11B15A69EQ38541804-2B3063EF-632C-4D36-976C-7BC30609FC6AQ38543189-983C4B0B-C40E-47EA-81ED-077B3477276EQ38813651-15379E1B-2D42-460E-B158-556638907625Q38848045-DA9544ED-322A-4DD4-A77F-785F30520552Q38932407-C64D1B3D-3B60-41C1-A98C-7486ED19E2CEQ40050746-A6781E02-12E4-4D4D-84F0-AAD53D4B7E10Q42100413-033C9F45-EC7E-45D0-ABB1-7C1CD409909EQ42138170-6E7C0F8C-1C33-427B-B883-F0D4EA728555Q42368155-CEAB7605-944E-46D2-8AB8-3BC838BD1BF1Q42643652-A1039231-2A0D-4BF6-A95F-4D13227731ECQ43476026-D226AF54-0EE9-477C-9EF3-55C5769A615AQ43488106-256D1CE2-3313-4798-9343-5FD849C1F590Q47791576-6EE450D8-854C-4DE4-8CA4-DB6716B38FCFQ48055170-32A8DFF7-DB4F-4507-B9C6-A860F4203215Q48240867-3F4AE9C7-D158-4029-AFF8-92103E5F7650Q49760238-001713E5-3DD0-4658-9EE6-DE9C4D546942
P2860
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Severe chronic allergic (and r ...... --GA2LEN--ARIA position paper.
@en
Severe chronic allergic
@nl
type
label
Severe chronic allergic (and r ...... --GA2LEN--ARIA position paper.
@en
Severe chronic allergic
@nl
prefLabel
Severe chronic allergic (and r ...... --GA2LEN--ARIA position paper.
@en
Severe chronic allergic
@nl
P2093
P2860
P50
P356
P1476
Severe chronic allergic (and r ...... --GA2LEN--ARIA position paper.
@en
P2093
A Andrianarisoa
A Bedbrook
A Ben Kheder
A El-Meziane
A Gamkrelidze
A M Chiriac
P2860
P304
P356
10.1159/000332924
P50
P577
2012-01-01T00:00:00Z